Ertugliflozin

5 trials 1 recruiting AGastroenterology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

4 Completed trials

5 Sponsors

13 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 3

Sponsors using this IMP

Amsterdam UMC 1 Eli Lilly & Co. 1 Eli Lilly Cork Limited 1 Merck Sharp & Dohme LLC 1 Universita Cattolica Del Sacro Cuore 1

All trials

5 total

SGLT-2i, Heart, Improvement of Cardiovascular Autonomic Neuropathy Recruiting

2025-521748-39-00 Phase IV 1 country Universita Cattolica Del Sacro Cuore
A Study of Daily Oral Orforglipron Compared with Insulin Glargine in Participants with Type 2 Diabetes and Obesity or Overweight at Increase… Ended

2022-502833-25-00 Phase III 8 countries Eli Lilly & Co.
DiEtary Sodium Intake effects on ertugliflozin-induced changes in GFR, reNal oxygenation and systemic hemodynamics: the DESIGN study, a rand… Ended

2023-510257-42-01 Phase IV 1 country Amsterdam UMC
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH) Ended

2022-500101-41-00 Phase IV 4 countries Eli Lilly Cork Limited
Ertugliflozin Pediatric Study Ended

2022-501085-21-00 Phase III 3 countries Merck Sharp & Dohme LLC

Showing 1–5 of 5 trials

← All drugs A–Z